Literature DB >> 32343992

Application of star poly(ethylene glycol) derivatives in drug delivery and controlled release.

Xiaobao Zhao1, Jingxing Si1, Dongsheng Huang1, Ke Li2, Ying Xin3, Meihua Sui4.   

Abstract

Multi-arm star poly(ethylene glycol) (PEG) polymers have a number of advantages over linear PEG polymers when used as carriers for drug delivery and controlled release. For instance, they have more terminals that can be modified to form multi-functional delivery systems with significantly increased drug loading. They can form micelles with higher stability and lower critical micelle concentration (CMC), which helps to improve the blood circulation and reduce the unfavorable burst drug release. Moreover, star PEG polymers can form three-dimensional hydrogels with controllable size and adjustable functions through cross-linking. Indeed, these unique advantages of star PEG polymers have promoted investigations on star PEG-based drug delivery systems. Herein, for the first time, we carefully reviewed the advances on the research and development of star PEG polymers, especially the 4-, 6- and 8-armed star PEG polymers, in delivery and controlled release of a series of bioactive agents, including both small molecules and biomacromolecules. Opportunities and challenges for successful translation of star PEG-based drug formulations into clinical use were also discussed.
Copyright © 2020. Published by Elsevier B.V.

Entities:  

Keywords:  Controlled release; Drug delivery; Multi-arm; Poly(ethylene glycol); Star polymer

Mesh:

Substances:

Year:  2020        PMID: 32343992     DOI: 10.1016/j.jconrel.2020.04.039

Source DB:  PubMed          Journal:  J Control Release        ISSN: 0168-3659            Impact factor:   9.776


  4 in total

1.  Application of the pH-Responsive PCL/PEG-Nar Nanofiber Membrane in the Treatment of Osteoarthritis.

Authors:  Zetao Wang; Yanping Zhong; Si He; Ruiming Liang; Chuanan Liao; Li Zheng; Jinmin Zhao
Journal:  Front Bioeng Biotechnol       Date:  2022-04-27

Review 2.  Emerging pro-drug and nano-drug strategies for gemcitabine-based cancer therapy.

Authors:  Haijie Han; Su Li; Yueyang Zhong; Yue Huang; Kai Wang; Qiao Jin; Jian Ji; Ke Yao
Journal:  Asian J Pharm Sci       Date:  2021-07-01       Impact factor: 6.598

Review 3.  Recent achievements in nano-based technologies for ocular disease diagnosis and treatment, review and update.

Authors:  Mehrdad Afarid; Shirin Mahmoodi; Roghayyeh Baghban
Journal:  J Nanobiotechnology       Date:  2022-08-02       Impact factor: 9.429

4.  Graphene Oxide Nanoplatforms to Enhance Cisplatin-Based Drug Delivery in Anticancer Therapy.

Authors:  Elena Giusto; Ludmila Žárská; Darren Fergal Beirne; Arianna Rossi; Giada Bassi; Andrea Ruffini; Monica Montesi; Diego Montagner; Vaclav Ranc; Silvia Panseri
Journal:  Nanomaterials (Basel)       Date:  2022-07-11       Impact factor: 5.719

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.